There was no difference in major cardiovascular events when statin initiation was based on coronary artery calcium compared with traditional risk factor assessment, according to results presented in a Hot Line session today at ESC Congress 2026.
Coronary Artery Calcium vs. Traditional Risk Factors: No Difference in Cardiovascular Events
New data presented at ESC Congress 2026 indicates that using coronary artery calcium for statin initiation does not lead to a difference in major cardiovascular events compared to traditional risk factor assessments. This research may influence healthcare practices in Iran, particularly in cardiovascular disease management. Understanding these findings is crucial for improving public health strategies in the country.
👥 Key Players
📰 What Happened
New research presented at the ESC Congress 2026 indicates that using coronary artery calcium scores for initiating statin therapy does not result in fewer major cardiovascular events compared to traditional risk factor assessments. This challenges previous assumptions about the effectiveness of coronary artery calcium in risk stratification.
- The study found no significant difference in cardiovascular outcomes between the two methods of statin initiation.
- This research could lead to changes in clinical guidelines for cardiovascular disease management.
💡 Why It Matters
📚 Background
Coronary artery calcium scoring is a method used to assess the risk of cardiovascular disease, while traditional risk factors include age, cholesterol levels, and blood pressure. This research questions the necessity of advanced imaging in routine practice.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%